Biomarker-guided precision immunotherapy in head and neck cancer: Harnessing toripalimab-tpzi as a PD-1 checkpoint inhibitor. // Advances in Biomarker Sciences and Technology. – URL: https://www.sciencedirect.com/science/article/pii/S2543106426000104?dgcid=rss_sd_all
Biomarker-guided precision immunotherapy in head and neck cancer: Harnessing toripalimab-tpzi as a PD-1 checkpoint inhibitor. Advances in Biomarker Sciences and Technology. https://www.sciencedirect.com/science/article/pii/S2543106426000104?dgcid=rss_sd_all
“Biomarker-guided precision immunotherapy in head and neck cancer: Harnessing toripalimab-tpzi as a PD-1 checkpoint inhibitor.” Advances in Biomarker Sciences and Technology.
@article{article33278,
title = {Biomarker-guided precision immunotherapy in head and neck cancer: Harnessing toripalimab-tpzi as a PD-1 checkpoint inhibitor},
journal = {Advances in Biomarker Sciences and Technology},
url = {https://www.sciencedirect.com/science/article/pii/S2543106426000104?dgcid=rss_sd_all}
}
ABSTRACT Three‐dimensional (3D) printing enables precise control over scaffold geometry, porosity, material distribution, and spatial delivery of cells and bioactive cues. However, features intended to improve biological fidelity often...